Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
25.37
-1.14 (-4.30%)
At close: Nov 20, 2026, 4:00 PM EST
25.42
+0.05 (0.20%)
After-hours: Nov 20, 2026, 7:30 PM EST
Alto Neuroscience Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
68
Market Cap
1.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 210.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
ANRO News
- 2 days ago - Alto Neuroscience Transcript: Jefferies Global Healthcare Conference - Transcripts
- 10 days ago - Alto Neuroscience Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 10 days ago - Alto Neuroscience Slides: Investor presentation - Filings
- 10 days ago - Alto Neuroscience reports Q3 EPS (54c), consensus (72c) - TheFly
- 10 days ago - Alto Neuroscience Reports Third Quarter 2026 Financial Results and Recent Business Highlights - Business Wire
- 10 days ago - Alto Neuroscience Earnings release: Q3 2026 - Filings
- 10 days ago - Alto Neuroscience Quarterly report: Q3 2026 - Filings
- 17 days ago - Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - Business Wire